LANGUAGE AND DURATION

  • Language: English
  • Duration - 60 minutes


PRESENTERS

 

SESSION AGENDA AND LEARNING OBJECTIVES

Session Agenda

  • Introductions
  • Overview of Treatments - Roberto Giugliani
  • Case Study - Roberto Giugliani
  • Expert Discussion
  • Audience Q&A
  • Close

Session Learning Objectives

  • Exploring the latest treatments for MPS in children and how care and management can be enhanced, including barriers to appropriate care and how to overcome them.
  • Understanding best practices and multidisciplinary care in the long-term management and monitoring of MPS.
  • Examining how to support the transition from pediatric to adult care.


COURSE DESCRIPTION

Misdiagnosis often leads to delayed recognition and treatment of Mucopolysaccharidosis (MPS), significantly affecting long-term patient outcomes. Commonly, MPS symptoms are mistaken for those of other ailments, leading to misdirected symptom management or referrals to inappropriate pediatric specialties. This can further delay accurate diagnosis and effective treatment. The Spot the Early Signs program is designed to combat conditions that are frequently underdiagnosed or diagnosed late. It focuses on diseases for which treatments exist and emphasizes the importance of early detection and intervention. These efforts are crucial for improving disease progression, enhancing patient quality of life, and increasing survival rates.


AUDIENCE

This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Endocrinologists, Pediatric Rheumatologists, and other physicians and healthcare professionals interested in Metabolic Diseases.

 

Watch the video!